June 13, 2017 Source: pharmatimes 146
A new method for extracting prostate biopsies has been awarded a £789,000 Invention for Innovation (i4i) Product Development Award by the National Institute for Health Research (NIHR).
CAMPROBE (Cambridge Prostate Biopsy Device) is a pioneering medical device designed to increase the safety and accuracy of prostate biopsies with the potential to change current practice.
Standard trans-rectal prostate biopsies carry significant risk of side effects such as urinary infections and severe sepsis as the needle crosses the bowel a number of times on the way to the prostate.
The CAMPROBE enables biopsies to be performed through the more sterile transperineal route under local anaesthesia in an outpatient setting.
In pilot trials the device resulted in no infections compared to rates of 5-12 percent from the current transrectal biopsy method, while 80 percent of men said they preferred the novel approach and would recommend it to a relative or friend.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.